Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation

被引:14
|
作者
Restelli, Valentina [1 ]
Vagni, Micaela [1 ]
Arribas, Alberto J. [2 ]
Bertoni, Francesco [2 ,3 ]
Damia, Giovanna [1 ]
Carrassa, Laura [1 ]
机构
[1] IRCCS, Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Mol Pharmacol, Milan, Italy
[2] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[3] IOSI Oncol Inst Southern Switzerland, Bellinzona, Switzerland
关键词
diffuse large B cell lymphoma; CHK1; WEE1; MYC; combined targeted therapy; PHASE; COMBINATION; CANCER;
D O I
10.1111/bjh.14506
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [1] Inhibition of Chk1 and Wee1 as an effective therapeutic approach in diffuse large B cell lymphomas: A way to target Myc?
    Vagni, M.
    Restelli, V.
    Lupi, M.
    Damia, G.
    Carrassa, L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S122 - S122
  • [2] Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma
    Carrassa, Laura
    Chila, Rosaria
    Basana, Alessandra
    Ricci, Francesca
    Guffanti, Federica
    Lupi, Monica
    Rinaldi, Andrea
    Cascione, Luciano
    Bertoni, Francesco
    Broggini, Massimo
    Damia, Giovanna
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
    Chila, Rosaria
    Basana, Alessandra
    Lupi, Monica
    Guffanti, Federica
    Gaudio, Eugenio
    Rinaldi, Andrea
    Cascione, Luciano
    Restelli, Valentina
    Tarantelli, Chiara
    Bertoni, Francesco
    Damia, Giovanna
    Carrassa, Laura
    ONCOTARGET, 2015, 6 (05) : 3394 - 3408
  • [4] Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
    Bruyer, Angelique
    Dutrieux, Laure
    de Boussac, Hugues
    Martin, Thibaut
    Chemlal, Djamila
    Robert, Nicolas
    Requirand, Guilhem
    Cartron, Guillaume
    Vincent, Laure
    Herbaux, Charles
    Lutzmann, Malik
    Bret, Caroline
    Pasero, Philippe
    Moreaux, Jerome
    Ovejero, Sara
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Combined inhibition of Chk1 and Wee1 kinases for cancer treatment
    Hauge, S.
    Hasvold, G.
    Joel, M.
    Naucke, C.
    Rodland, G. E.
    Syljuasen, R. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S478 - S478
  • [6] Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
    Davies, Kurtis D.
    Cable, P. LouAnn
    Garrus, Jennifer E.
    Sullivan, Francis X.
    von Carlowitz, Ira
    Le Huerou, Yvan
    Wallace, Eli
    Woessner, Richard D.
    Gross, Stefan
    CANCER BIOLOGY & THERAPY, 2011, 12 (09) : 788 - 796
  • [7] Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma
    Russell, Mike
    Levin, Kirill
    Rader, JulieAnn
    Toniatti, Carlo
    Maris, John M.
    Cole, Kristina A.
    CANCER RESEARCH, 2012, 72
  • [8] Chk1 inhibition and Wee1 inhibition combine synergistically to inhibit cellular proliferation
    Davies, Kurtis D.
    Sullivan, Francis
    von Carlowitz, Ira
    Le Huerou, Yvan
    Wallace, Eli
    Woessner, Richard D.
    Gross, Stefan
    CANCER RESEARCH, 2011, 71
  • [9] Combined Inhibition of ChK1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients
    Bruyer, Angelique
    de Boussac, Hugues
    Martin, Thibaut
    Kassambara, Alboukadel
    Robert, Nicolas
    Cartron, Guillaume
    Hose, Dirk
    Seckinger, Anja
    Pasero, Philippe
    Moreaux, Jerome
    BLOOD, 2017, 130
  • [10] Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
    Di Rora, Andrea Ghelli Luserna
    Bocconcelli, Matteo
    Ferrari, Anna
    Terragna, Carolina
    Bruno, Samantha
    Imbrogno, Enrica
    Beeharry, Neil
    Robustelli, Valentina
    Ghetti, Martina
    Napolitano, Roberta
    Chirumbolo, Gabriella
    Marconi, Giovanni
    Papayannidis, Cristina
    Paolini, Stefania
    Sartor, Chiara
    Simonetti, Giorgia
    Yen, Timothy J.
    Martinelli, Giovanni
    CANCERS, 2019, 11 (11)